erlotinib hydrochloride has been researched along with cyclopamine in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (cyclopamine) | Trials (cyclopamine) | Recent Studies (post-2010) (cyclopamine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 658 | 0 | 343 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | cyclopamine (IC50) |
|---|---|---|---|
| Integrin beta-1 | Homo sapiens (human) | 1.312 | |
| Integrin alpha-4 | Homo sapiens (human) | 1.312 | |
| Smoothened homolog | Mus musculus (house mouse) | 1.271 | |
| Sonic hedgehog protein | Homo sapiens (human) | 0.6 | |
| Sonic hedgehog protein | Mus musculus (house mouse) | 0.7373 | |
| Smoothened homolog | Homo sapiens (human) | 0.2147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airiau, K; Avril, T; Belaud-Rotureau, MA; Belloc, F; Dugay, F; Eimer, S; Quillien, V | 1 |
1 other study(ies) available for erlotinib hydrochloride and cyclopamine
| Article | Year |
|---|---|
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Comparative Genomic Hybridization; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Flow Cytometry; Fluorescent Antibody Technique; Glioblastoma; Humans; In Situ Hybridization, Fluorescence; Neoplastic Stem Cells; Quinazolines; Veratrum Alkaloids | 2012 |